What medications can increase appetite in patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications to Increase Appetite

Megestrol acetate (400-800 mg/day) is the most effective appetite stimulant with evidence for weight gain, but should be monitored for side effects including thromboembolic events and fluid retention, and discontinued if ineffective after 4 weeks. 1

First-Line Medications

Megestrol Acetate

  • Dosage: 400-800 mg/day (most effective dose range)
  • Evidence: Strongest evidence for appetite stimulation and weight gain
  • Mechanism: Progestational agent that stimulates appetite through unclear mechanisms
  • Benefits:
    • Significant appetite improvement (95% of patients showed improvement after 2 weeks) 2
    • Weight gain (non-fluid)
    • Improved quality of life in cancer and AIDS patients
  • Risks:
    • Thromboembolic events (relative risk 1.84)
    • Edema (relative risk 1.36)
    • Increased mortality risk (relative risk 1.42)
  • Practical considerations:
    • Lower starting doses (80 mg twice daily) may be effective and reduce side effects 3
    • Dose-response effect exists for appetite stimulation 4

Mirtazapine

  • Dosage: 15-30 mg daily
  • Evidence: Demonstrated weight gain in patients with dementia (1.9 kg after three months) 5
  • Benefits:
    • Additional benefits for sleep difficulties and mood disorders
    • Approximately 80% of dementia patients experience weight gain
  • Risks:
    • FDA warnings include serotonin syndrome, QTc prolongation, and increased appetite/weight gain 6
    • Not recommended for weight loss without depression 5

Alternative Options

Cyproheptadine

  • Dosage: 2-4 mg three times daily
  • Evidence: Well-established safety profile in pediatric patients 1
  • Best for: Pediatric patients requiring appetite stimulation

Dexamethasone

  • Dosage: 2-8 mg/day
  • Evidence: Provides rapid appetite stimulation 1
  • Best for: Short-term use in patients with limited life expectancy
  • Caution: Limit duration due to side effects (muscle wasting, insulin resistance)

Olanzapine

  • Dosage: 5 mg/day
  • Evidence: Alternative with fewer thromboembolic risks than megestrol acetate 1
  • Caution: Monitor for metabolic side effects

Treatment Algorithm

  1. Assess underlying cause of appetite loss (depression, cancer, AIDS, dementia, etc.)
  2. Start with megestrol acetate 400 mg/day for most patients
    • For elderly or frail patients, consider starting at 160 mg/day
    • For patients with depression or sleep issues, consider mirtazapine 15-30 mg daily instead
  3. Monitor after 2-4 weeks for:
    • Appetite improvement
    • Weight gain
    • Side effects (especially thromboembolic events)
  4. Adjust treatment:
    • If effective with no significant side effects: continue
    • If ineffective: increase dose (up to 800 mg/day for megestrol acetate)
    • If side effects occur: reduce dose or switch medication

Important Considerations

  • Combination with non-pharmacological approaches is essential:

    • Small, frequent meals (5-6 per day)
    • High-calorie, nutrient-dense foods
    • Pleasant eating environment
    • Moderate physical activity when possible
  • Common pitfalls:

    • Failing to monitor for thromboembolic events with megestrol acetate
    • Not discontinuing ineffective medication after 4 weeks
    • Using high-dose steroids for prolonged periods
    • Overlooking non-pharmacological interventions
  • Special populations:

    • Elderly: Start with lower doses and monitor closely for side effects
    • Cancer patients: Megestrol acetate shows particular benefit 2, 7
    • Dementia patients: Mirtazapine may be beneficial if depression is present 5
  • Monitoring recommendations:

    • Regular weight measurements
    • Appetite assessment
    • Screening for edema and thromboembolic events
    • Quality of life assessment

Remember that while these medications can improve appetite and weight, they should be used as part of a comprehensive approach to nutrition and should be discontinued if ineffective after an adequate trial period.

References

Guideline

Appetite Stimulation in Pediatric and Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Megestrol acetate for treatment of anorexia-cachexia syndrome.

The Cochrane database of systematic reviews, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.